Drug Detail:Peramivir (Peramivir [ per-am-i-vir ])
Drug Class: Neuraminidase inhibitors
Peramivir Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because peramivir is poorly absorbed orally, it is not likely to reach the bloodstream of the infant in clinically important amounts. However, because no information is available on the use of peramivir breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Oseltamivir, Zanamivir
Substance Identification
Substance Name
Peramivir
CAS Registry Number
330600-85-6
Drug Class
-
Breast Feeding
-
Lactation
-
Antiviral Agents
-
Neuraminidase Inhibitors
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification